IDEAYA Biosciences (IDYA) Reports In-Line Q4 EPS

IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($0.94), in-line with the analyst estimate of ($0.94). Revenue for the quarter came in at $10.88 million versus the consensus estimate of $6.12 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Deutsche Bank Downgrades Man Group Plc. (EMG:LN) (MNGPY) to Hold